Next Article in Journal
Partial Characterization of an Enzymatic Extract from Bentong Ginger (Zingiber officinale var. Bentong)
Next Article in Special Issue
Berberine, an Epiphany Against Cancer
Previous Article in Journal
Rumphellaones B and C, New 4,5-Seco-Caryophyllane Sesquiterpenoids from Rumphella
Previous Article in Special Issue
α-Solanine Inhibits Invasion of Human Prostate Cancer Cell by Suppressing Epithelial-Mesenchymal Transition and MMPs Expression
Article Menu

Export Article

Open AccessReview
Molecules 2014, 19(8), 12328-12335;

PM00104 (Zalypsis®): A Marine Derived Alkylating Agent

University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195, USA
Fred Hutchinson Cancer Research Center, University of Washington, 825 Eastlake Avenue East, G-3630, Seattle, WA 98109-1023, USA
These authors contributed equally to this work.
Author to whom correspondence should be addressed.
Received: 25 July 2014 / Revised: 11 August 2014 / Accepted: 11 August 2014 / Published: 15 August 2014
(This article belongs to the Special Issue Alkaloids: Novel Therapeutic Perspectives)
Full-Text   |   PDF [657 KB, uploaded 15 August 2014]   |  


PM00104 (Zalypsis®) is a synthethic tetrahydroisoquinolone alkaloid, which is structurally similar to many marine organisms. The compound has been proposed as a potential chemotherapeutic agent in the treatment of solid human tumors and hematological malignancies. PM00104 is a DNA binding agent, causing inhibition of the cell cycle and transcription, which can lead to double stranded DNA breaks. After rigorous pre-clinical testing, the drug has been evaluated in a number of phase II clinical trials. This manuscript provides a review of current trials and appraises the efficacy of PM00104 as a future cancer treatment. View Full-Text
Keywords: PM00104; Zalypsis; alkaloid; chemotherapy; cancer therapy PM00104; Zalypsis; alkaloid; chemotherapy; cancer therapy

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Petek, B.J.; Jones, R.L. PM00104 (Zalypsis®): A Marine Derived Alkylating Agent. Molecules 2014, 19, 12328-12335.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top